PMID: 11925309Apr 2, 2002Paper

Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors

The American Journal of Psychiatry
Gerard SanacoraJohn H Krystal

Abstract

Studies have demonstrated low concentrations of gamma-aminobutyric acid (GABA) in the plasma and CSF of individuals with major depression, and low GABA concentrations have also been found in the occipital cortex of depressed subjects. The goal of this study was to determine whether these occipital cortex GABA concentrations are altered after administration of selective serotonin reuptake inhibitors (SSRIs) in the treatment of depression. By means of proton magnetic resonance spectroscopy, occipital cortex GABA concentrations were measured in 11 medication-free depressed patients before initiation of treatment with SSRI medications and after an average of 2 months of treatment. A significant increase in occipital cortex GABA concentrations was seen after SSRI treatment. SSRI treatment of major depression is associated with increased occipital cortex GABA concentrations. This appears to result in a normalization of low pretreatment GABA concentrations, an effect that may contribute to a common mechanism of antidepressant action.

Citations

Nov 8, 2006·Archives of General Psychiatry·Matthew J TaylorZubin Bhagwagar
Jun 13, 2006·Psychopharmacology·S SelvarajP J Cowen
Oct 13, 2006·Psychopharmacology·Terumichi TakahashiShigeto Yamawaki
Apr 18, 2009·European Journal of Clinical Pharmacology·Esra KüçükibrahimoğluM Zafer Gören
Nov 6, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Ursula M H KlumpersWitte J G Hoogendijk
Jun 1, 2010·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Brooke H MillerMathew T Pletcher
Apr 25, 2012·European Archives of Psychiatry and Clinical Neuroscience·Tomasz GosBernhard Bogerts
Oct 12, 2012·Archives of Pharmacal Research·Ji Who KimDong Soo Lee
Mar 26, 2013·Drug and Alcohol Dependence·Andrew P PrescotDeborah A Yurgelun-Todd
Nov 20, 2002·Biological Psychiatry·Justine M KentJack M Gorman
Aug 21, 2003·Progress in Neurobiology·Mark J Millan
Nov 17, 2010·Molecular Psychiatry·B LuscherN Sahir
Oct 21, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gianluigi GuidottiMarco A Riva
Aug 9, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Kejia CaiC Neill Epperson
Jan 11, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Koji OhiraTsuyoshi Miyakawa
Oct 26, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Grazyna RajkowskaJose Javier Miguel-Hidalgo
Jul 13, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lee E SchechterChad E Beyer
May 30, 2007·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Chris C StreeterPerry F Renshaw
Aug 21, 2010·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Chris C StreeterJ Eric Jensen
Apr 7, 2005·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Masamoto YokoyamaHitoshi Miyaoka
Sep 9, 2006·Clinical Neuropharmacology·Mauricio SierraAnthony S David
Apr 14, 2009·Topics in Magnetic Resonance Imaging : TMRI·Stephen R DagerStefan Posse
Dec 6, 2008·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Jadranka Culav-SumićVlado Jukić
Feb 14, 2007·Journal of Gastroenterology and Hepatology·Yi-Chia LeeMing-Shiang Wu
Jan 19, 2011·Epilepsia·Andres M Kanner
Jun 7, 2011·Reviews in the Neurosciences·Christopher F Sharpley, Linda L Agnew
Jul 17, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Julie D GolombZubin Bhagwagar
Feb 21, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Lee E SchechterSharon Rosenzweig-Lipson
Jun 9, 2012·International Journal of Nanomedicine·Sahar M Kamal
Nov 20, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Shane A PerrineMatthew P Galloway
Apr 11, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Andres M KannerMatthias Koepp
May 17, 2014·AJNR. American Journal of Neuroradiology·T-S LeeK R R Krishnan
Jan 20, 2007·Cellular and Molecular Neurobiology·Erin M MacKenzieGlen B I Baker
Apr 3, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Amelie Soumier, Etienne Sibille
Aug 2, 2014·Psychiatry Research·Stephanie C LicataScott E Lukas
Jan 24, 2012·AJNR. American Journal of Neuroradiology·L M Levy, A J Degnan
Jun 13, 2009·Cellular and Molecular Life Sciences : CMLS·Cristina LanniCinzia Boselli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.